Skip to main content

Table 1 Effects of transiently pENTR/U6-expressed shRNAS on CDV replication

From: Multi-targeted gene silencing strategies inhibit replication of Canine morbillivirus

shRNA construct

Log10 reduction valuea and CPE scoreb

pENTR/U6-shRNA (μg)

0.25

 

0.5

 

0.75

 

1

 

qRT-PCR

TCID50

CPE

qRT-PCR

TCID50

CPE

qRT-PCR

TCID50

CPE

qRT-PCR

TCID50

CPE

Ni1

1.35a

1.17a

3.0

2.14b

1.67b

2.0

2.23b

3.28c

1.3

2.65c

3.28c

1.0

Ni2

0.71a

1.22a

3.0

1.48b

2.22b

2.3

1.92c

3.00b

1.8

2.53d

3.00b

1.0

Ni3

1.12a

1.28a

3.0

1.63b

2.44b

2.3

2.03bc

2.78b

1.3

2.29c

2.78b

1.0

Li1

ns

ns

4.0

0.29a

0.61a

3.0

0.27ab

0.50a

3.0

0.41b

0.78a

2.0

Li2

0.26a

0.50a

3.0

0.36ab

0.56a

3.0

0.39b

0.50a

3.0

0.31ab

0.56a

2.3

Li3

ns

ns

4.0

0.12a

ns

3.0

0.17a

ns

3.0

0.27b

0.72a

2.0

SCR

ns

ns

4.0

ns

ns

4.0

ns

ns

4.0

ns

ns

4.0

Ni shRNAs associationc

Ni1 (1.2 μg)

Ni2 (1.2 μg)

Ni3 (1.2 μg)

Ni1 + Ni2 + Ni3 (0.4 μg each)

2.54b

3.1a

1.0

1.90a

3.1a

1.0

1.92a

3.1a

1.0

1.87a

3.1a

1.0

  1. aThe log10 reduction was calculated by subtracting the log10 means of the CDV infectivity in the presence of transfected shRNA constructs from the log10 means of the CDV infectivity in the absence of shRNAs
  2. bCPE scores were defined as (1) CPE < 25%, (2) CPE between 25 and 50%, (3) CPE between 51 and 75% and (4) CPE > 75%. CPE values correspond to the CPE score means for replicates
  3. cAssociation of pENTR/U6-shRNAs against CDV nucleoprotein
  4. Values followed by the same lowercase letters in horizontal lines do not differ within each method; p < 0.01 (Tukey’s test)
  5. Ni plasmid shRNA for CDV nucleoprotein mRNA, Li plasmid shRNA for CDV large protein mRNA, SCR plasmid scramble shRNA, ns (not statistically significant): no significant difference between shRNA-treated and untreated CDV infected cells